Key Lung Cancer Multidisciplinary Trials: Highlights from 2023 and What's Coming in 2024

Moderator(s)

• 

  Jessica Donington, MD (she/her/hers)

  Chief Thoracic Surgery
  University of Chicago
  Chicago, Illinois, United States
• 

  Luis Tapias, MD

  Assistant Professor of Surgery
  Mayo Clinic
  Rochester, Minnesota, United States

Presentations:

• 9:45 AM – 9:55 AM CT

  Neoadjuvant and "Sandwich" Lung Cancer Trials
  

  Invited Speaker: Jonathan David Spicer, MD, PhD, FRCSC – Division of Thoracic Surgery, McGill University
• 9:55 AM – 10:07 AM CT

  Limited Uptake of Adjuvant Chemotherapy for Stage II-III Non-Small-Cell Lung Cancer in the United States: Implications for Adherence to Novel Adjuvant Treatment Modalities
  

  Presenting Author: Arvind Kumar (he/him/his) – Icahn School of Medicine at Mt. Sinai
• 10:07 AM – 10:17 AM CT

  Adjuvant Lung Cancer Trials
  

  Invited Speaker: Brendon Stiles, MD – Montefiore Health System / Albert Einstein School of Medicine
• 10:17 AM – 10:29 AM CT

  Outcomes of Patients with cT3-4N2 NSCLC in the Era of Modern Systemic Therapy: Is it Time to Redefine Resectability?
  

  Presenting Author: Jorge Humberto Rodriguez Quintero, MD – Montefiore Medical Center / Albert Einstein College of Medicine
• 10:29 AM – 10:41 AM CT

  Revisiting N3 Non-Small Cell Lung Cancer: Assessing Survival Parallels to N2 Disease and the Impact of Neoadjuvant Therapy with Surgery
  

  Presenting Author: Aria Bassiri, MD – University Hospital Cleveland Medical Center
• 10:41 AM – 10:51 AM CT

  Stage III Trials
  

  Invited Speaker: Linda W. Martin, MD, MPH – University of Virginia
• 10:51 AM – 11:15 AM CT

  Tumor Board Discussion
  

  Panelist: Jonathan David Spicer, MD, PhD, FRCSC – Division of Thoracic Surgery, McGill University

  Panelist: Brendon Stiles, MD – Montefiore Health System / Albert Einstein School of Medicine

  Panelist: Linda W. Martin, MD, MPH – University of Virginia